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Abstract
Background: Previous studies showed higher sepsis mortality rates in Brazil compared to other developed or developing
countries. Moreover, another trial demonstrated an increased mortality rate in public hospitals compared to private
hospitals in Brazil. The reasons for these findings may include delayed recognition and inadequate treatment of sepsis in
public facilities. We designed this study to evaluate the factors associated with mortality in septic patients admitted to
intensive care units in a network of public and private institutions.
Materials and Methods: This study is a retrospective analysis of a prospective cohort of sepsis patients in 19 private and
public institutions in Brazil. We analyzed data from the original database and collected additional data to assess compliance
to the treatment guidelines and to determine the time from the onset of organ dysfunction and the sepsis diagnosis by the
healthcare team.
Results: A total of 396 patients were analyzed. Patients in public hospitals were younger, had a greater number of
dysfunctional organs at baseline and a lower chance to have sepsis diagnosed within two hours of the onset of organ
dysfunction. Private hospitals had a better compliance to lactate and blood culture sampling and maintenance of glycemic
control. The multivariate analysis showed that age, disease severity at baseline and being treated at a public hospital were
independent risk factors for mortality. A delay in the sepsis diagnosis of longer than two hours was associated with mortality
only in the public setting.
Conclusions: We confirmed a lower sepsis mortality rate in the private hospitals of this network. Being treated in a public
hospital was an independent factor for mortality. Delayed recognition of sepsis was more frequent in public institutions and
this might have been associated with a higher mortality. Improving sepsis recognition and early diagnosis may be important
targets in public institutions.
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Introduction
Sepsis is the leading cause of death in non-cardiac intensive care
units (ICUs) around the world, with high death rates especially in
underdeveloped and developing countries [1–5]. In Brazil, several
studies already showed high mortality rates [6–8] that are even
higher than in other developing countries such as Argentina and
India [9]. The reasons for this finding are not clear. A case mix
can partially explain this observation in Brazil because there are
significant inequalities in access to health care and a shortage of
ICU beds [10]. In addition, all previous epidemiological studies
included only ICU patients, which are possibly the most severe
cases of sepsis. However, this high mortality could also be
associated with delayed recognition and inadequate treatment of
sepsis.
In a previous multicenter study, a difference in mortality rates
between the public and private hospitals in Brazil was clearly
demonstrated [6]. However, only five centers were involved, and
from these, only one was a private institution. In the COSTS
study, an epidemiological cohort trial aiming to analyze sepsis-
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Table 1. Main characteristics according to the type of hospital.
Variable
Patients at public
hospitals (N=258)
Patients at
private hospitals (N=138)
Univariate analysis
p value
Multivariate analysis
p value OR(CI95%)
Age (years) 59 (44–73) 68 (51–81) 0.0004 ,0.0001
1.03 (1.01–1.04)
Male gender 159 (61.6) 80 (58.0) 0.54 –
APACHE II 23 (21–28) 21 (16–27) 0.15 NS
SOFA dysfunction 6 (5–9) 6 (4–8) 0.22 –
SOFA diagnosis 7 (5–10) 7 (4–9) 0.04 NS
DeltaSOFA 0.0(0.0–1.0) 0.0(0.0–0.0) 0.02 NS
Comorbidities 194 (75.2) 85 (85.9) 0.04 NA
Respiratory 26 (10.1) 9 (9.1) 0.93 –
Renal 30 (11.8) 15 (15.3) 0.48 –
Cardiovascular 91 (30.5) 50 (50.5) 0.01 NA
Neurological 26 (10.4) 22 (22.2) 0.006 NA
Immunossuppression 66(25.6) 23 (23.2) 0.74 –
Diabetes mellitus 44 (17.3) 18 (18.2) 0.97 –
Hepatic 19 (7.4) 6 (6.1) 0.84 –
Classification
Clinical 142 (54.9) 62 (62.6) 0.22 –
Surgical 116 (45.1) 37 (37.4)
Septic shock 118 (45.7) 81 (58.7) 0.01 NS
Infection type
Community-acquired 112 (43.4) 69 (50.0) 0.22 NS
Nosocomial (ward) 103 (39.9) 43 (31.2)
Nosocomial (ICU) 43 (16.7) 26 (18.8)
Site of diagnosis
Emergency room 73 (28.3) 48 (34.8) 0.36 –
Ward 118 (45.7) 60 (43.5)
ICU 67 (26.0) 30 (21.7)
Source of infection
Pulmonary 134 (51.9) 70 (50.7) 0.82 –
Intraabdominal 64 (24.8) 14 (10.1) 0.001 0.020
0.40 (0.19–0.87)
Urinary 20 (7.8) 18 (13.0) 0.11 NS
Other 40(15.5) 36 (26.2)
Organ dysfunction (n) 2.0(2.0–3.0) 2.0(1.0–3.0) ,0.0001 0.005
0.70 (0.55–0.89)
Cardiovascular 148 (57.4) 76 (55.1) 0.73 –
Respiratory 212 (82.2) 105 (76.1) 0.18 NS
Renal 114 (44.2) 43 (31.2) 0.01 NS
Metabolic 68 (26.4) 22 (15.9) 0.02 NS
Hematological 72 (27.9) 25 (18.1) 0.04 NS
Hepatic 50 (19.4) 10 (7.2) 0.002 NS
Time to the sepsis diagnosis (h) 6(1.2–20.0) 3(0.0–11.0) 0.01 NA
Diagnosis in one hour 61 (23.9) 54 (39.1) 0.002 0.032
1.85 (1.05–3.33)
Diagnosis in two hours 71(27.8) 61 (44.2) 0.001 0.049
1.75(1.01–3.03)
Compliance with the sepsis bundles*
Lactate sampling 39 (15.1) 77 (55.8) ,0.0001 ,0.0001
5.59(3.16–9.91)
Blood cultures 42 (16.3) 47 (34.1) ,0.0001 ,0.0001
3.26(1.75–6.09)
Sepsis in Public and Private Hospitals in Brazil
PLOS ONE | www.plosone.org 2 June 2013 | Volume 8 | Issue 6 | e64790
related costs in 21 Brazilian institutions, the mortality rates for the
public and private hospitals were significantly different (49.1% and
36.7%, respectively) [7]. Possible reasons for these findings are
differences in the profiles of the two healthcare systems, differences
in the treated populations, promptness of the diagnosis or
adequacy of treatment. Although differences in mortality rates in
teaching and non-teaching hospitals were shown [1,11], differ-
ences related to the type of healthcare system (public vs. private)
were not clearly reported. Thus, this study aimed to identify the
risks factors associated with sepsis mortality in these two different
types of institutions in Brazil using the COSTS database, a robust
multicenter observational prospective study.
Methods
This study is a post-hoc analysis of the patients included in the
COSTS study, which was carried out in 21 Brazilian public and
private ICUs [7]. The original trial screened all of the patients
admitted to these ICUs from October 1, 2003 to March 30, 2004.
All patients older than 18 years of age with a diagnosis of sepsis,
severe sepsis or septic shock were prospectively included after
signed informed consent. Briefly, patients were eligible for
inclusion if they had two or more signs of systemic inflammatory
response syndrome secondary to a known or suspected infection.
The presence of at least one sepsis-induced organ dysfunction was
required for the diagnosis of severe sepsis and fluid refractory
hypotension and vasopressors use characterized the diagnosis of
septic shock. Patients were excluded if they were pregnant or if
their physicians were not committed to full life support. In this
posthoc analysis, we analyzed only the severe sepsis and septic
shock patients.
Sepsis-induced organ dysfunction, assessed at the moment of
sepsis diagnosis, was considered to be one of the following:
hypotension, an arterial oxygen partial pressure/oxygen inspira-
tory fraction (PaO2/FiO2) ratio #300, lactate level $1.5 times the
reference value and base deficit .5, bilirubin level .2 times the
reference value, urine output #0.5 ml/kg/hour after adequate
volume replacement or the need for renal replacement therapy,
platelet count#100,000 mm3 or a decrease of 50% from the last 3
days’ values, or a reduced level of consciousness. Septic shock was
defined as volume-refractory hypotension with need for vasopres-
sors at any time during the sepsis episode. We considered public
institutions to be hospitals in which the main source of revenue
was the National Healthcare System (Sistema Unico de Saude –
SUS) and private institutions to be hospitals in which the main
billing system was based on health insurance.
Information related to the time to sepsis diagnosis and adequacy
of treatment were retrospectively obtained from medical records.
The time to the sepsis diagnosis was defined as the number of
hours elapsed between the onset of the first organ dysfunction and
the recognition and management of sepsis by the healthcare
provider. We defined sepsis recognition as the documentation of a
sepsis diagnosis in the patient’s chart. To identify the timing of
organ dysfunction, the charts were carefully reviewed to determine
the first recording of hypotension, reduced level of consciousness
or low urine output as well as the first laboratory sampling time in
Table 1. Cont.
Variable
Patients at public
hospitals (N=258)
Patients at
private hospitals (N=138)
Univariate analysis
p value
Multivariate analysis
p value OR(CI95%)
Antibiotics 164 (63.6) 61 (44.6) ,0.0001 NS
Time from diagnosis to antibiotics (h)** 0 (0–4) 2.3 (0–8) ,0.0001 NA
Time from dysfunction to antibiotics (h)** 10.8 (3.5–29.3) 8,5(3.0–19.9) p = 0.267 NA
Fluid resuscitation 107 (71.3) 56 (60.2) 0.09 NA
Vasopressors 94 (81.0) 65 (79.3) 0.89 –
CVP optimization 15 (13.0) 31 (37.3) ,0.0001 NA
ScvO2 optimization 2 (1.8) 12 (14.6) 0.001 NA
Glycemic control 67 (26.0) 72 (52.2) ,0.0001 0.001
2.45(1.42–4.24)
Corticosteroids use 26(23.4%) 27(34.2%) 0.14 NA
Drotrecogin use 5(1.9%) 2(1.5%) 0.73 –
Entire 6-h bundle 1 (0.4) 2 (1.4) 0.58 –
Daily costs (R$)*** 1,835.9
(1,478.1–2,273.4)
2,041.2
(1,504.6–2,781.7)
0.003 0.002
1.01(1.00–1.01)
Total costs (R$)*** 19,922.2
(9,255.2–41,118.2)
17,335.0
(9,186.5–35,480.9)
0.32 –
Length of ICU stay
ICU mortality
Hospital mortality 157 (60.9) 65 (47.1) 0.01 0.005
0.44 (0.25–0.78)
APACHE–Acute Physiological and Chronic Health Evaluation, SOFA–Sequential Organ Failure Assessment, ICU–intensive care unit, CVP–central venous pressure, ScvO–
central venous oxygen saturation, OR–odds ratio, CI–confidence interval, NS–non-significant, NA–not applicable, significant variable in the univariate analysis but not
included in the multivariate analysis due to missing data. The results are expressed as a number (%) or median (25%–75%). *Total number of patient variables according
to the bundle evaluated [(fluid resuscitation (n = 243), vasopressors (n = 198), CVP and Scv0? (n = 197)]. ** only those not in previous antibiotics use or in whom the
previous antibiotics was changed. (public: n = 115, public: n = 187).*** Approximately currency: 1R = 1.8 US. Chi-squared and Mann Whitney tests (univariate). Diagnosis
within one hour was included in the multivariate analysis. Multivariate analysis with stepwise forward regression, reference: private hospitals. Hosmer-Lemeshow test
p = 0.41.
doi:10.1371/journal.pone.0064790.t001
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which the results fulfilled the respiratory, metabolic, coagulation or
hepatic criteria for organ dysfunction. In patients admitted from
the emergency department already with severe sepsis criteria, we
used the time of triage. The SOFA scores [12]were determined at
the beginning of organ dysfunction and at the time of the sepsis
diagnosis. We determined the delta SOFA as the difference
between the SOFA at the onset of dysfunction and the SOFA at
the time of the sepsis diagnosis.
We also assessed the compliance with the Surviving Sepsis
Campaign (SSC) [13] bundles, considering the moment of the
sepsis diagnosis as the baseline. We used the SSC criteria to define
adherence [14]. Time to antibiotics was calculated as the time
elapsed between the diagnosis of severe sepsis/septic shock and the
first dose of intravenous antibiotics. This analysis was restricted to
those patients not under antibiotics or those who had previous
antibiotics changed because of the current sepsis episode. In the
24–h bundles, only the compliance to glycemic control was
analyzed. We did not evaluate the compliance to corticosteroids
and activated protein C as, according to SSC, this is defined by
following or not institutional protocols. However, we collected
data on their use. The data for plateau pressure was inconsistent in
the charts; thus, this parameter was not collected.
To minimize possible biases in the retrospective data collection,
especially regarding the determination of the onset of organ
dysfunction and the time of the sepsis diagnosis, data were
collected by only two authors (KC for 89% and FGRF for 11% of
the sites). They were not blind to the patients’ identification and
mortality outcome, as this information was available in the charts.
However, they were instructed to check the information on the
sepsis episode before assessing mortality. Although they collected
data on their own hospitals, they were not in charge of those
patients during the original study. Any controversy was discussed
with the senior author (FRM).
All other data were retrieved from the original database,
including the costs analysis. In the original study, we assessed all
enrolled patients daily, analyzing cost related expenditures and all
interventions were priced in a standardized fashion. This strategy
allowed us to use costs as a measurement of the intensity of clinical
support and quality of care, thus we included it in our risk factor
analysis.
For the present study, all of the original sites were invited to
participate. The Research Ethics Committee from the coordinat-
ing institution (Comiteˆ de E´tica em Pesquisa - UNIFESP) and all
of the other institutions that agreed to participate in the present
study approved the protocol and waived the need for a new
informed consent.
Statistical Analysis
We described categorical variables as percentages and contin-
uous variables by their central tendency and dispersion according
to their distribution, as assessed by the Kolmogorov-Smirnov test.
We used the Mann-Whitney and Pearson chi squared tests for
continuous and categorical data, as appropriate.
Our aim was to address the differences between public and
private institutions, as well as the risk factors for mortality. Thus,
we did two different multivariate logistic stepwise forward
regression models. In the first one, we assess the characteristics
that were independently associated with each type of institution. In
the second, we analyze the risk factors for mortality in the global
population as well as in each type of institution. All of the variables
in the univariate analysis that had a p value below 0.2 were
included in a multivariate logistic stepwise forward regression
model. In this analysis, we decided not to include variables with
missing data for more than 50 patients because the lack of data
would result in serious inconsistencies. The model calibration was
assessed using the Hosner-Lemeshow test, which was considered to
Figure 1. Study flowchart.
doi:10.1371/journal.pone.0064790.g001
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Table 2. Risk factors for hospital mortality (global analysis).
Variable
Survivors
(N=174)
Non-survivors
(N=222)
Univariate
analysis
p value
Multivariate analysis
p value–OR(CI95%)
Age (years) 57 (39–70) 66 (51–70) ,0.0001 ,0.0001
1.03 (1.02–1.04)
Male gender 102 (58.6) 137 (61.7) 0.53 –
APACHE II 19 (14–23) 24 (19–29) ,0.0001 0.002
1.05 (1.02–1.08)
SOFA dysfunction 6 (4–8) 7 (5–9) ,0.0001 NS
SOFA diagnosis 6 (4–8) 8 (6–10) ,0.0001 NS
Comorbidities 101 (67.3) 178 (86.0) ,0.0001 NA
Respiratory 8 (5.3) 27 (13.0) 0.01 NA
Renal 13 (8.7) 32 (15.8) 0.04 NA
Cardiovascular 56 (37.3) 85 (41.1) 0.47 –
Neurological 27 (18.0) 21 (10.6) 0.04 NA
Immunossuppression 31 (20.7) 58 (28.0) 0.11 NA
Diabetes mellitus 25 (16.7) 37 (18.2) 0.70 –
Hepatic 6 (4.0) 19 (9.3) 0.05 NA
Classification
Clinical 77 (51.3) 126 (61.2) 0.08 NA
Surgical 73 (48.7) 80 (38.8)
Septic shock 86 (49.4) 113 (50.9) 0.77 –
Infection type
Community-acquired 89 (51.2) 92 (41.5) 0.07# NS
Nosocomial (ward) 54 (31.0) 92 (41.5 )
Nosocomial (ICU) 31 (17.8) 38 (17.0)
Site of diagnosis
Emergency Room 60 (34.5) 61 (27.5) 0.25 –
Ward 71 (40.8) 107 (48.2)
ICU 43 (24.7) 54 (24.3)
Source of infection
Pulmonary 84 (48.3) 120 (54.1) 0.66 –
Intraabdominal 35 (20.1) 43 (19.1)
Urinary 19(10.9) 19 (8.6)
Other 47 (20.7) 48 (18.2)
Organ dysfunction 2.0761.1 2.6361.2 ,0.0001 NS
Cardiovascular 90 (51.7) 134 (60.4) 0.08 NS
Respiratory 136 (78.2) 181 (81.5) 0.40 –
Renal 54 (31.0) 103 (46.4) 0.002 NS
Metabolic 35 (20.1) 55 (24.8) 0.27 –
Hematological 28 (16.1) 69 (31.1) ,0.0001 0.024
1.93(1.09–3,41)
Hepatic 18 (10.3) 42 (18.9) 0.01 NS
Hospital characteristics
Public 101(58.0) 157(70.7) 0.009 0.001
2.55 (1.50–4.32)
Private 73 (42.0) 65 (29.3) 0.034
Daily costs(R$)*** 1,696.0
(1,377.0–2,003,7)
2,070.9
(1,644,2–2,599,9)
0.0001 ,0.0001
1.001(1.001–1.001
Total costs(R$)*** 20,578,0
(7,966,8–34,063,7)
19,085
(10,092,0–41,872,1)
0.22 –
Time to the sepsis diagnosis (h) 4 (0–12) 6 (11–21) 0.006 NS
Diagnosis in one hour 62 (35.8) 53 (24.1) 0.01 NS
Sepsis in Public and Private Hospitals in Brazil
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be appropriate if p above 0.10. The time to the sepsis diagnosis
was categorized using the receiver operating characteristic (ROC)
curve for mortality. Because having sepsis diagnosed within either
one or two hours had a similar sensitivity and specificity, we run
separate multivariate analyses using both variables as well as the
original continuous values. We chose to express the results with the
two-hour cut off in the comparison between the public and private
hospitals because these results had a better calibration in the
Hosner-Lemeshow test. However, we also reported the OR (IC
95%) results for the 1-hour cut off when this variable remained in
the model. We did a collinearity diagnosis and also run the model
with/without hospital type to assess the changes in odds ratios
among the other variables.
The patient clustering in two groups (public and private
hospital) resulted in two imbalanced groups (Table 1). In order
to adjust for these differences, we fit a propensity score [15,16].
Propensity score analyses are able to take into account as much
variables related to the outcome as needed, reducing bias [17]. We
included variables related both to patient location (public or
private) and to outcome (hospital mortality). To assess the
balancing of covariates between public and private groups in
each propensity score quintile, we drew side-by-side box plots of
the estimated propensity scores for patients from public and
private hospitals within each quintile of the propensity scores [16].
To generate the propensity score we included in a multivariate
logistic regression all variables related both to the exposure and the
outcome with P value less than 0.20 in the univariate analysis in
both table 1 and 2 [16,18]. We decide to include variables related
to outcome as this would possible add to our score variables linked
to some other relevant and unknown variables related to exposure.
This inclusion would increase the precision of the estimated
exposure effect without increasing bias according to recent
findings. [16,19] The score was finally entered as a continuous
variable into the logistic regression model, with hospital mortality
as dependent variable and patient location as independent variable
[15,16,20]. This logistic regression analysis took into account the
hospital clustering effect. We evaluated the calibration ability for
the model using the Hosmer-Lemeshow goodness-of-fit test.
Table 2. Cont.
Variable
Survivors
(N=174)
Non-survivors
(N=222)
Univariate
analysis
p value
Multivariate analysis
p value–OR(CI95%)
Diagnosis in two hours 68(39.3) 64(29.1), 0.03 NS
Compliance with the sepsis bundles*
Lactate sampling 57 (32.8) 59 (26.6) 0.18 NS
Blood cultures 38 (21.8) 51 (23.0) 0.78 –
Antibiotics 99 (56.9) 126 (56.8) 0.97 –
Time from diagnosis to antibiotics (h)** 0.48 (0–4.56) 0 (0–6.48) 0.36 –
Fluid resuscitation 75 (72.1) 88 (63.3) 0.15 NA
Vasopressors 67 (80.7) 92 (80.0) 0.95 –
CVP optimization 26 (30.6) 20 (17.7) 0.05 NA
ScvO2 optimization 7 (8.3) 7 (6.2) 0.76 –
Glycemic control 74 (42.5) 65 (29.3) 0.006 0.026
0.57 (0.35–0.93)
Entire 6-h bundle 2 (1.1) 1 (0.5) 0.83 –
APACHE–Acute Physiological and Chronic Health Evaluation, SOFA–Sequential Organ Failure Assessment, ICU–intensive care unit, CVP–central venous pressure, ScvO–
central venous oxygen saturation, OR–odds ratio, CI–confidence interval, NS–non-significant, NA–not applicable, significant variable in the univariate analysis but not
included in the multivariate analysis due to missing data. The results are expressed as a number (%) or median (25%–75%). *Total number of patient variables according
to the bundle evaluated [(fluid resuscitation (n = 243), vasopressors (n = 198), CVP and Scv0? (n = 197)]. ** only those not in previous antibiotics use or in whom the
previous antibiotics was changed. (public: n = 115, public: n = 187).*** Approximately currency: 1R = 1.8 US. Chi-squared and Mann Whitney tests (univariate).
Multivariate analysis with stepwise forward regression, reference: non-survivors. Hosmer-Lemeshow test p = 0.19.
doi:10.1371/journal.pone.0064790.t002
Figure 2. Comparison of propensity scores for patients from
public and private hospitals within each propensity score
quintile. The groups are comparable because there is sufficient
overlap in the propensity score within each block.
doi:10.1371/journal.pone.0064790.g002
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Table 3. Risk factors for hospital mortality according to the type of institution.
Public hospitals Private hospitals
Characteristics
Survivors
(n =101)
Non-survivors
(n =157)
p value
OR (IC 95%)**
Survivors
(n =73)
Non-survivors
(n=65)
p value
OR (IC 95%)**
Age (years) 52 (38–66) 62 (50–76) 0.001
1.03(1.01–1.04)
62 (47–76) 72 (58–86) 0.001
1.04(1.02–1.06)
Male gender 63 (62.4) 96 (61.1) 39 (53.4) 41 (63.1) –
APACHE II 19,0 (14,0–24,0) 25,0 (20,0–30,0) 0.002
1.07(1.02–1.11)
19.0 (14.0–25.0) 23.0 (18.0–28.0) NS
SOFA dysfunction 6.0 (4.0–8.0) 7.0 (5.0–9.0) NS 5.0 (3.0–8.0) 7.0 (5.0–10.0) NS
SOFA diagnosis 6.0 (5.0–9.0) 8.0 (6.0–10.0) NS 5.0 (3.0–8.0) 8.0 (6.0–10.0) 0.003
1.221(1.07–1.40)
Comorbidities 63 (62.4) 131 (83.4) NA 38 (77.6) 47 (94.0) NA
Respiratory 6 (5.9) 20 (12.7) – 2 (4.1) 7 (14.0) –
Renal 6 (5.9) 24 (15.7) NA 7 (14.6) 8 (16.0) –
Cardiovascular 31 (30.7) 60 (38.2) – 25 (51.0) 25 (50.0) –
Neurological 14 (13.9) 12 (19.0) – 13 (26.5) 9 (18.0) –
Immunossuppression 19 (18.8) 47 (29.9) NA 12 (24.5) 11 (22.0) –
Diabetes mellitus 15 (14.9) 29 (8.1) NA 10 (20.4) 8 (16.0) –
Hepatic 6 (5.9) 13 (8.4) – 0 (0.0) 6 (12.0) NA
Classification
Clinical 49 (48.5) 92 (59.0) NA 28 (57.1) 34 (68.0) –
Surgical 52 (51.5) 64 (41.0) 21 (42.9) 16 (32.0) –
Septic shock 44 (43.6) 74 (47.1) 42 (57.5) 39 (60.0) –
Infection type
Community–acquired 50 (49.5) 62 (39.5) NS 39 (53.4) 30 (46.2) –
Nosocomial (ward) 30 (29.7) 73 (46.5) 24 (32.9) 19 (29.2) –
Nosocomial (ICU) 21 (20.8) 22 (14.0) 10 (13.7) 16 (24.6 –
Site of diagnosis
Emergency room 32 (37.1) 41 (26.1) – 28 (38.4) 20 (30.8) –
Ward 40 (39.6) 78 (49.7) 31 (42.5) 29 (44.6) –
ICU 29 (28.7) 38 (24.2) 14 (19.2) 16 (24.6) –
Source of infection
Pulmonary 50 (49.5) 84 (53.5) – 34 (46.6) 34 (55.4) –
Intraabdominal 26 (25.7) 39 (24.8) 9 (12.3) 5 (7.7)
Urinary 9 (8.9) 11 (7.0) 10 (13.7) 8 (12.3)
Other 16 (15.8) 24 (15.3) 20 (27.4) 16 (24.6)
Organ dysfunction 2.2261.2 2.8061.2 NS 1.8761.0 2.2160.9 NS
Cardiovascular 53 (52.5) 95 (60.5) NS 37 (50.7) 39 (60.0) –
Respiratory 80 (79.2) 132 (84.1) – 56 (76.7) 49 (75.4) –
Renal 34 (33.7) 80 (51.0) NS 20 (27.4) 23 (35.4) –
Metabolic 24 (23.8) 44 (28.0) – 11 (15.1) 11 (16.9) –
Hematological 17 (26.8) 55 (35.0) 0.041
2.08(1.03–4.20)
11 (15.1) 14 (21.5) –
Hepatic 16 (15.8) 34 (21.7) – 2 (2.7) 8 (12.3) NS
Daily costs(R$)*** 1,649.9
(1,319,7–1,895.4)
1,978.3
(1,612.7–2.395.0)
0,001
1.001(1.000–1.001)
1,781.3
(1,463.3–2,198.9)
2,412.2
(1,894.2–3,035.4)
,0.0001
1.001(1.000–1.002)
Total costs(R$)*** 21,818.3
(8,441.0–39,593.3)
19,055.4
(10.032,9–41.118,2)
– 16,518.6
(7,569.6–28,129.3)
19,267.6
(10,236.6–42,071.1)
–
Time to the sepsis diagnosis (h) 5(0.48–13.00) 8(2.32–29.00) NS 3.36 (0.0–10.24) 2.32 (0.0–11.28) –
Diagnosis in one hour 35 (35) 26 (16.8) 0.004
0.37 (0.19–0.73)
27 (37.0) 27 (41.5) –
Diagnosis in two hours 39(39.0) 32(20.6) 0.005
0.40(0.22–0.77)
29(39.7) 32(49.2) –
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Statistical analysis was done using SPSS 17.0 package for
Windows and GraphPad Prism 5 for Windows H - version 5.0–
2007.
Results
We analyzed 396 patients out of 524 who were originally
included in the COSTS study. Forty-two patients were not
included because they had sepsis without organ dysfunction. Three
of the original centers did not agree to participate in this study, two
public and one private, totaling 47 patients. In addition, data were
missing for 39 patients from the current participating sites. To
summarize, a total of 86 patients with severe sepsis or septic shock
were not included in the present study (Figure 1). Ultimately, we
included patients from 18 of the 21 original sites. Of these sites,
nine centers were characterized as public hospitals and nine as
private hospitals. The participating centers are listed in Table S1.
Differences between the Public and Private Hospitals
According to the multivariate analysis, there were some
characteristics significantly associated with the public and private
hospitals (Table 1). Patients admitted to private hospitals were
older and were more likely to be diagnosed with sepsis within two-
hours of the onset of organ dysfunction. In addition, private
Table 3. Cont.
Public hospitals Private hospitals
Characteristics
Survivors
(n =101)
Non-survivors
(n =157)
p value
OR (IC 95%)**
Survivors
(n =73)
Non-survivors
(n=65)
p value
OR (IC 95%)**
Compliance with the sepsis
bundles*
Lactate sampling 15 (14.9) 24 (15.3) – 42 (57.5) 35 (53.8) –
Blood cultures 13 (12.9) 29 (18.5) – 25 (34.2) 22 (33.8) –
Antibiotics 67 (66.3) 97 (61.8) – 32 (43.8) 29 (44.6) –
Time from diagnosis to
antibiotics (h)**
0 (0–2.40) 0 (0–4.08) – 2.16 (0–5.52) 2.16 (0–10.32) –
Fluid resuscitation 42 (79.2) 65 (67.0) NA 33 (64.7) 23 (54.8) –
Vasopressors 33 (80.5) 61 (81.3) – 34 (81.0) 31 (77.5) –
CVP optimization 6 (14.6) 9 (12.2) – 18 (42.9) 11 (28.2) –
ScvO2 optimization 1 (2.4) 1 (1.4) – 6 (14.0) 6 (15.4) –
Glycemic control 27 (26.7) 40 (25.5) – 47 (64.4) 25 (38.5) ,0.0001
0.20(0.08–0.49)
Entire 6-h bundle 0(0) 1 (0.6) – 2 (2.4) 0 (0) –
APACHE–Acute Physiological and Chronic Health Evaluation, SOFA–Sequential Organ Failure Assessment, ICU–intensive care unit, CVP–central venous pressure, ScvO–
central venous oxygen saturation, OR–odds ratio, CI–confidence interval, NS–non-significant, NA–not applicable, significant variable in the univariate analysis but not
included in the multivariate analysis due to missing data. The results are expressed as a number (%) or median (25%–75%).* Total number of patients variable according
to the bundle. **Multivariate analysis with stepwise forward regression, reference: non-survivors. ** only those not in previous antibiotics use or in whom the previous
antibiotics was changed. (public: n = 115, public: n = 187).*** Approximately currency: 1R = 1.8 US. Hosmer-Lemeshow for public hospitals p = 0.93, private hospitals
p = 0.26.
doi:10.1371/journal.pone.0064790.t003
Figure 3. Mortality according to the time of the sepsis diagnosis in public and private hospitals. NS: Non-significant.
doi:10.1371/journal.pone.0064790.g003
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hospitals had higher daily costs and a better compliance to lactate
and blood culture sampling and maintenance of glycemic control.
In contrast, public hospitals had a higher prevalence of
intraabdominal infections, more organs with dysfunction and
higher mortality. In the univariate analysis, the SOFA score at the
onset of organ dysfunction was similar between the two types of
hospitals (Table 1). However, the SOFA score, delta SOFA and
the number of organs with dysfunction at the moment of diagnosis
were higher in the public hospitals.
Assessment of Mortality Risk Factors
In the multivariate analysis, older age, higher APACHE II
score, higher daily costs, poorer glycemic control, the presence of
hematological dysfunction and being admitted to a public hospital
were associated with a higher mortality (Table 2). The time to the
sepsis diagnosis did not remain in the multivariate model. There
was no relevant collinearity between the variables included in the
model.
The propensity score was as patients and their scores were
equality distributed among the score quintiles within the groups
(Figure 2). Our model has an AUC of 0.846 to predict the type of
hospital. The logistic regression analysis with hospital mortality as
dependent variable and patient location as independent variable,
including the propensity score as a continuous variable confirmed
the type of institution as a independent factor associated with
mortality (OR 1.719 CI95%: 1.040–2.843, p = 0.036), with a good
calibration by the Hosmer-Lemeshow test (p = 0.841). We also
separately analyzed the factors associated with mortality in each
type of hospital (Table 3). In the public hospitals, in the
multivariate analysis, the variables associated with mortality were
age, APACHE II score, the presence of hematologic dysfunction
and daily costs. Compared to the non-survivors, among the
survivors, there was a higher proportion of patients in whom the
sepsis diagnosis was made either within one or two hours. In the
private hospitals, the variables that remained in the logistic
regression model were only age, SOFA score at the time of
diagnosis, daily costs and glycemic control. As opposite of the
findings in public hospitals, the time to the sepsis diagnosis was not
different between the survivors and non-survivors in the private
setting (Table 3).
Although the global mortality rates were higher in the public
hospitals, there was no difference when we evaluated the patients
in whom the diagnosis of sepsis was made within one hour of the
onset of organ dysfunction (42.6% vs. 50% for public and private
institutions, p = 0.45). Thus, this significant difference between the
two types of hospitals is solely due to increased mortality in the
public setting among those diagnosed after one hour (66.5% vs.
45.2%, p,0.001) (Figure 3). These results remained unchanged
when the two-hour cut-off was used (data not shown).
As we missed data for 86 patients in the retrospective analysis,
we also compared those patients with our main group (n= 396).
There were no significant differences between the groups in age,
gender, APACHE II, SOFA score or the distribution according to
the type of hospital (public or private). There were 18 patients still
alive at the ICU on day 60 (main group: 16(4.0%); missing group:
2(2.3%, p= 0.414). In the mortality assessment, we adopted a
conservative approach and considered dead all patients still in the
ICU at the 60th day in the subgroup of missing patients. In the
main group, as we have data on hospital mortality, we considered
all patients that died in the hospital as died during ICU stay. There
was no significant difference in mortality rates between the two
groups (main group: 49.5%, missing group: 44.2%, p= 0.371).
The difference in mortality rates between the two types of
institutions remained significant when we analyzed the whole
group (n= 482: public hospitals: 52.4% vs. private hospitals:
41.6%, p= 0.023) (Table S2).
Discussion
In this study, septic patients admitted to private hospitals in
Brazil had lower mortality rates compared to patients admitted to
public facilities. Being treated in a public hospital was associated
with a higher mortality in the multivariate analysis. In addition,
having sepsis diagnosed within one or two hours after the onset of
organ dysfunction was significantly associated with reduced
mortality in public hospitals but not in private ones.
In our study, the sepsis mortality rate was independently
associated with admission to public institutions, although no clear
differences could be found between the two types of institutions
regarding the severity of illness as assessed by APACHE and
SOFA scores. This higher mortality in the public hospitals was
already suggested by previous studies [6,7]. However, in this study,
for the first time, public hospitals were independently associated
with a higher mortality in a multivariate analysis, where both
timely diagnosis and adequate treatment were assessed. There are
some possible explanations for our findings.
The time elapsed between the onset of organ dysfunction and
the time to the sepsis diagnosis in public hospitals was twice that of
private hospitals. This delay in diagnosis might have contributed
to our findings of a higher SOFA score, higher delta SOFA and
more organ dysfunction in the public hospitals at the moment of
diagnosis. These findings reinforce the hypothesis that septic
patients in public facilities are recognized late, and ICU admission
occurs at a later stage of disease when several organs already
presented dysfunction. A previous study in a public emergency
room in Brazil demonstrated a significant delay in emergency care
and transfer to the ICU, sometimes retarding proper treatment
[21]. This observation was corroborated by another study carried
out in a Brazilian teaching hospital, where delayed admission of
critically ill patients to the ICU (most of them were septic) was
associated with increased mortality [22]. There is significant
evidence that delayed treatment is associated with a higher
mortality; however, there is a paucity of data about the impact of
delayed diagnosis, although this conclusion might be considered
intuitive. In a public Brazilian hospital, Freitas et al. demonstrated
a strict association between the time to sepsis diagnosis and
mortality, with a mean delay of 1.7 days [23]. Westphal et al., in a
before-after trial in two Brazilian ICUs, showed that the time
between the first record in the charts of at least two signs suggestive
of infection and the time of diagnosis of severe sepsis was
significantly higher in non-survivors. After implementing a sepsis
treatment protocol, they were able to show an improvement in
sepsis recognition and mortality [24]. Another study also
correlated an increased time between the onset of hypoperfusion
and the beginning of fluid resuscitation with a higher mortality
[25]. All of the findings reported in these studies may be related to
deficiencies in the physicians’ knowledge regarding the basic
concepts of the disease. Indeed, a previous survey undertaken in
Brazil showed that doctors have not mastered the concepts of
sepsis and severe sepsis [26]. In this study, we clearly showed that a
delay in the sepsis diagnosis was associated with a higher mortality
in public institutions. The reason why we could not demonstrate
this association in the private hospitals is not clear. Certainly,
because the delay in diagnosis is minor in private hospitals, an
early recognition would have less impact on the overall quality of
care provided. The impact would be even less if the quality of care
is better, as it seemed to be in the private institutions where the
overall compliance with the bundles was better. It should be
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noticed that public hospitals had a shorter time to antibiotics and a
better compliance with antibiotics and volume/vasopressors. This
was expected as in some private hospitals antibiotics could not be
delivered in the emergence department before a full admission in
the hospital, which needed authorization by the health insurance
company. However, it should also be emphasized that as
compliance was measured considering the moment of sepsis
diagnosis and not the onset of organ dysfunction the delay in sepsis
recognition in public settings would potentially create a paradox-
ical situation of compliance to an important goal not contributing
to reduced mortality.
Other potential explanations for the higher mortality rates in
the public institutions include an unfavorable patient-healthcare
professional ratio, non-optimized processes and a lack of adequate
infrastructure in these settings, which could potentially be related
to increased mortality. Although we did not assess other quality
indicators, indirect evidence of better quality of care and support is
our finding of higher daily costs in the private institutions.
Moreover, all of the Brazilian studies only analyzed patients
admitted to intensive care. This access is more limited in public
hospitals, where usually only the more severe cases go to the ICU.
Even if properly recognized as sepsis, these patients may arrive at
the ICU in a later stage of disease with established organ
dysfunction and therefore increased risk of death. Other issues that
may contribute to this difference include heterogeneity in health-
care access in Brazil [6], mainly in the public health network.
Limited access may result in a delay in reaching the emergency
services. The time needed to reach emergence services might be
quite difference between these two types of institution as well as
the percentage of patients transferred from hospital to hospital
before a proper diagnosis is made. Differences in global quality of
life and health might also play a role, such as worse control of co-
morbidities and baseline inadequate nutritional status, baseline
socio-economic status, in patients treated in public hospitals.
This study has some strengths. First, this multicenter study
evaluated ICUs from several Brazilian hospitals with a consider-
able number of patients. The inclusion was consecutive during the
original study, and the prospective data collection ensures that the
variables reported here are robust and reasonably representative of
national characteristics. Most of the patients included in the
original trial were also evaluated in this one. In addition, the
systematic assessment of the time to the sepsis diagnosis is unique
in the literature.
This study also has several limitations. First, data from the
original study were collected in 2004, and improvements in sepsis
recognition and treatment may have occurred since then.
However, single center studies and data from the SSC suggest
that compliance with the SSC guidelines is still low in Brazil
[23,27,28]. Second, we were unable to adequately characterize
demographic data regarding the ethnicity and socioeconomic
status of our population as well as the presence of comorbidities.
We also did not collect length of hospital stay or any other long-
term mortality, which precludes a cox proportional hazards
regression that could have reinforced our findings. Third, we
carried out a retrospective analysis of compliance and the time to
the sepsis diagnosis. Although the information on compliance
could be retrieved from the records more objectively, precisely
determining the timing of diagnosis of organ dysfunction and
treatments from the charts tend to be more subjective. Another
limitation is a probable selection bias because we just analyzed
patients admitted to the ICU; thus, our results might not be
representative of other hospital settings. It is possible also that our
results do not represent the Brazilian reality, as most of our
hospitals are located in the Southeast and South regions, the
richest regions in Brazil. Actually, it is probable that in the other
regions the differences in these two healthcare systems are even
greater, as the gap in quality of care between private and public
tends to be reinforced in poorest regions. Our hypothesis needs to
be confirmed in a prospective study with an adequate sample size
and randomly selection of ICU and hospitals in all Brazilian
regions.
Conclusion
We demonstrate that septic patients admitted to Brazilian public
hospitals have a higher mortality than those admitted to private
hospitals, although they have similar disease severity. Delayed
recognition is more frequent in public institutions and this might
have been associated with a higher mortality. Thus, improving
sepsis recognition and early diagnosis should be important targets
to improve the care of septic patients in public institutions.
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